Seattle Genetics Announces Data from ECHELON-1 Phase 3 Clinical Trial of ADCETRIS in Newly Diagnosed Advanced Hodgkin Lymphoma Presented at ASH 2018  Continue to Show Superior Clinical Activity of ADCETRIS in Combination with AVD vs ABVD